NCT01719380 2021-06-23Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal CancerPfizerPhase 2 Completed156 enrolled 41 charts
NCT02550743 2021-03-12BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group StudyBrown UniversityPhase 1 Terminated7 enrolled 7 charts